1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Medicover AB (publ)

Medicover AB (publ)

MCOV-B.ST
Medicover AB (publ)SE flagStockholm Stock Exchange
204.50
SEK
+1.00
- -
30.88BMarket Cap
Medicover AB (publ)
MCOV-B.ST
(Stockholm Stock Exchange)

Recent

price

209.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.74
3.12
5.23
4.87
5.04
6.33
7.04
9.28
10.16
11.69
13.95
15.78
15.03
Revenue per Share
0.03
0.06
0.05
0.16
0.17
0.17
0.18
0.69
0.08
0.12
0.11
0.51
0.29
Basic EPS, GAAP
-0.01
-0.02
-0.87
0.18
-0.06
-0.29
0.58
0.77
0.2
0.63
0.93
1.23
1.05
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
0.07
0.12
0.12
0.12
0.15
0.15
Dividend per Share
0.46
0.52
0.84
0.09
0.25
0.39
0.57
1.16
1.04
1.07
0.69
1.08
0.81
Book Value per Share
-0.16
-0.24
-0.54
1.15
0.87
-0.09
0.92
0.78
-0.76
-0.74
-1.12
-1.78
-2.11
Tangible Book Value per Share
133
133
95
119
133
133
142
148
149
149
150
151
150
Basic Weighted Avg Shares
365
416
497
580
672
844
998
1,377
1,510
1,746
2,092
2,378
2,258
Sales/Revenue/Turnover
4.6
5.17
4.24
4.96
5.02
5.54
6.59
11.57
3.75
3.5
4.14
6.55
4.77
Operating Margin (%)
18
18
23
26
57
74
96
111
162
183
198
215
222
Depreciation Expense
4
8
4
19
22
22
26
102
12
18
17
78
43
Net Income, GAAP
63.57
46.11
47.15
27.86
23.66
25.83
26.81
25.87
29.74
22.03
27.36
26.12
28.31
Effective Tax Rate (%)
1.18
1.8
0.86
3.22
3.32
2.66
2.59
7.39
0.78
1.01
0.8
3.26
1.92
Profit Margin (%)
-72
39
37
36
59
-66
61
227
-22
-119
-120
-211
-69
Working Capital
- -
126
195
138
223
306
318
675
838
775
981
1,095
1,187
LT Debt
90
93
99
300
318
360
484
562
508
528
489
545
485
Total Equity
- -
5.46
4.12
5.24
4.87
4.98
5.75
10.68
2.82
3.16
3.83
6.13
4.29
Return on Invested Capital (%)
- -
4.11
1.82
8.58
11.51
7.25
7.29
15.28
3.23
4.89
4.8
8.69
6.52
Return on Capital (%)
- -
11.51
5.79
41.19
99.33
52.39
38.77
80.57
7.22
11.19
12.68
58.03
31.61
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
258
248
237
LT Borrowings
543
560
746
LT Finance Leases
438
437
441
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
150
150
151
Market Capitalization
2,498
2,618
3,380

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
447
481
477
Cash, Cash Equivalents & STI
83
113
89
Accounts Receivable, Net
212
306
329
Inventories
69
62
59
Total Current Liabilities
566
565
546
Payables & Accruals
- -
- -
- -
ST Debt
258
248
237
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
27.76%
2.92%
11.36%
Free Cash Flow
394.41%
52.88%
32.95%
Net Income, GAAP
94.13%
122.85%
364.07%
Sales/Revenue/Turnover
19.28%
19.36%
13.69%
Total Cash Common Dividend
- -
- -
25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
499
509
528
556
2,092
2025
578
597
612
- -
2,378
2026
624
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.04
-0.03
0.06
0.11
2025
0.13
0.13
0.12
- -
0.51
2026
0.15
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.12
- -
- -
0.12
2025
- -
0.15
- -
- -
0.15
2026
- -
- -
- -
- -
- -
Similar Companies
Kt Medical Service Public Company Limited (KTMS.BK)
Medicover AB (publ) (MCVEF)
Talkspace, Inc. (TALKW)
Bumrungrad Hospital Public Company Limited (BUGDF)
Fresenius SE & Co. KGaA (FRE.DE)
Human Health Holdings Limited (1419.HK)
Business
Medicover AB (publ) delivers comprehensive healthcare and diagnostic solutions across Europe and India, maintaining its headquarters in Stockholm, Sweden. The company operates through distinct divisions: Healthcare Services and Diagnostic Services. Its healthcare arm encompasses primary care, specialized outpatient and inpatient treatments, fertility clinics, dental facilities, hospitals, and wellness centers. Within diagnostic services, Medicover provides an extensive array of laboratory tests for human health, covering areas such as allergy and autoimmune conditions, microbiology, clinical chemistry, hematology, histopathology, molecular biology, and genetics, alongside some veterinary diagnostics. This is all supported by a wide-reaching "hub-and-spoke" laboratory network. Serving a diverse clientele including corporate entities, private individuals, and public healthcare systems, Medicover focuses on growth in Central and Eastern European markets, as well as India. Its operational footprint spans Germany, Poland, Romania, Ukraine, Bosnia-Herzegovina, Bulgaria, Croatia, Cyprus, Georgia, Greece, Moldova, North Macedonia, Turkey, Serbia, Slovenia, and India, among others. Medicover reported robust financial performance in the third quarter of 2025, with revenues climbing to €591.6 million and a positive shift in net income year-over-year. Recent strategic movements include the acquisition of SYNLAB Group’s businesses in several Central and Eastern European countries in April 2025, significantly expanding its diagnostic reach with additional laboratories and blood-drawing points. In India, Medicover Hospitals, which already operates 23 hospitals and two cancer centers, is evaluating a potential separate listing and plans further expansion with new hospital openings. The company, established in 1995, also saw a leadership transition with John Stubbington appointed as the new CEO in May 2025.